Oropharyngeal Squamous Cell Carcinoma Clinical Trials in San Francisco, California
2 recruitingSan Francisco, California
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7+6 more
National Cancer Institute (NCI)613 enrolled341 locationsNCT01810913
Recruiting
People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
HIV InfectionsOral Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma
University of California, San Francisco144 enrolled1 locationNCT06055868